— CATEGORY · 4 COMPOUNDS

Angiogenic & tissue research compounds

Angiogenic and tissue research peptides studied in preclinical tissue-response models for their roles in angiogenesis, cellular migration, extracellular matrix remodelling, and structural protein regulation.

This category contains BPC-157, among the most extensively studied repair-focused compounds in rodent research, and TB-500, a synthetic analogue of thymosin beta-4 studied for its actin-regulating effects in cellular migration. Both are also investigated alongside each other in tissue-repair research protocols.

For in vitro research use only. Compounds in this category are not for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition.

Compounds in angiogenic & tissue research

Angiogenic & Tissue Research

KPV

£34.99 £24.99
Explore all curated multi-compound bundles View all 10 research bundles →

Frequently asked — angiogenic & tissue research

What compounds does Velox Peptides supply for angiogenic and tissue research?
Velox Peptides supplies 3 research compounds in this category: BPC-157, TB-500, BPC-157 & TB-500. All are HPLC-verified by a third-party laboratory.
Are these peptides for human use?
No. All compounds supplied by Velox Peptides are strictly for in vitro research use by qualified researchers. They are not medicinal products and are not for human or veterinary consumption.
How are research peptides supplied?
Research compounds are supplied as lyophilised (freeze-dried) powders in sterile vials for reconstitution with bacteriostatic water prior to research use. See our reconstitution calculator for concentration and volume calculations.
Is purity documentation available?
Yes. Batch documentation is available on request. Previous batch CoAs are available in our CoA library.
Compliance statement. Velox Peptides supplies research reagents for in vitro use by qualified researchers. Every compound is sold strictly as a research reagent. No product is a medicinal product within the meaning of the Human Medicines Regulations 2012. No product has been evaluated by the MHRA or FDA. No product is intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition. Any use outside lawful scientific research is outside the scope of sale. See our Research Use Policy and MHRA Statement.